| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.35 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |